Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect our body? And what's left to learn?

Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

We don't know how a caloric deficit caused by taking a GLP-1 would alter that development," said Dr. Brian Erly ...

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Dr. Patricia Brubaker and Dr. Pieter Cohen are the speakers at this year’s Trottier Public Science Symposium, Monday at 7 p.m ...

EMA endorses Novo Nordisk's Wegovy for treating heart failure and lowering heart risks in obese patients. Second approval ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Novo Nordisk has announced positive Phase IIa results for monlunabant, a small molecule oral CB1 inverse agonist for obesity.

Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...